✦ LIBER ✦

Elevation of plasma aspartylglucosaminidase is a useful marker for the congenital disorders of glycosylation type I (CDG I)

✍ Scribed by M. Jackson; P. Clayton; S. Grunewald; G. Keir; K. Mills; P. Mills; B. Winchester; V. Worthington; E. Young

Publisher: Springer
Year: 2005
Tongue: English
Weight: 85 KB
Volume: 28
Category: Article
ISSN: 0141-8955
DOI: 10.1007/s10545-005-0157-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transferrin mutations at the glycosylati

Transferrin mutations at the glycosylation site complicate diagnosis of congenital disorders of glycosylation type I

✍ Mailys Guillard; Yoshinao Wada; Hana Hansikova; Isao Yuasa; Katerina Vesela; Nin 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 272 KB

Congenital disorder of glycosylation typ

Congenital disorder of glycosylation type 1a in a macrosomic 16-month-old boy with an atypical phenotype and homozygosity of the N216I mutation

✍ Luitgard M. Neumann; Arpad von Moers; Jürgen Kunze; Oliver Blankenstein; Thorste 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 245 KB

Functional analysis of three splicing mu

Functional analysis of three splicing mutations identified in the PMM2 gene: Toward a new therapy for congenital disorder of glycosylation type Ia

✍ Ana I. Vega; Celia Pérez-Cerdá; Lourdes R. Desviat; Gert Matthijs; Magdalena Uga 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

The congenital disorders of glycosylation (CDG) are a group of diseases caused by genetic defects affecting N-glycosylation. The most prevalent form of CDG-type Ia-is caused by defects in the PMM2 gene. This work reports the study of two new nucleotide changes (c.256-1G>C and c.640-9T>G) identified